If patients have other symptoms associated with febrile neutropeniaincluding. Febrile neutropenia fn is a serious adverse effect of myelosuppressive chemotherapy that can affect treatment by contributing to dose delays and reductions. Neutropenic fever is when there is a single oral temperature of greater than or equal to 101 f, or a temperature greater than or equal to 100. Identify patients who are at risk of developing febrile neutropenia indicate the time frame in which febrile neutropenia treatment should be initiated recognize healthcare worker actions that may reduce febrile neutropenia occurrence guidelines nccn. Interpretation of study results in light of ncagncepod findings. Febrile neutropenia guidelines update and approach to management of both high and intermediaterisk paents bernardo rapoport the medical oncology centre of rosebank, johannesburg and. To describe oncology nurses use of national comprehensive cancer network nccn clinical practice guidelines for chemotherapyinduced neutropenia cin and febrile neutropenia. Jan 10, 2019 febrile neutropenia is defined as a onetime oral temperature of greater than 38. Empirical antibiotic therapy upon presentation has dramatically improved outcomes and decreased mortality from febrile neutropenia. Signs and symptoms of infection from febrile neutropenia2 fever chills and sweats change in cough or new cough sore throat or new mouth sore. Outpatient management of fever and neutropenia in adults. Dec 29, 2017 febrile neutropenia fn is among the most serious clinical complications in patients with cancer who are undergoing chemotherapy. Patients with a history of febrile neutropenia are at risk for subsequent episodes of febrile neutropenia, and many professional societies including the american society of clinical oncology asco, the national cancer center network nccn.
The national comprehensive cancer network nccn establishes standard of care for patients receiving anticancer therapy, and classifies regimens based on febrile neutropenia fn and emesis risks. Neutropenia has been recognized as a major risk fac. Guidelines in the management of febrile neutropenia for clinical. Clinical judgment is recommended when determining which patients are candidates for outpatient management, using clinical criteria or a validated tool such as the multinational association. Initial evaluation of fever and neutropenia fev1 initial risk assessment for febrile neutropenic patients fev2 outpatient therapy for lowrisk patients fev3 initial empiric therapy for fever and neutropenia fev5 sitespecific evaluation and therapy. In addition to the increased risk of infection, neutropenia negatively impacts quality of life and places cancer patients at risk for. Any physician using these guidelines to provide treatment. All of these factors have fostered new treatment approaches. In the absence of serious infections, gcsf is not indicated to improve clinical outcomes, but may reduce hospitalization by 1 day. Optimal management of neutropenic fever in patients with.
For the most recent version of the guidelines, please visit nccn. Sep 07, 2018 the nccn and the asco guidelines for the use of growth factors recommend that all patients receiving highrisk chemotherapy should receive neutropenia prophylaxis with a granulocytecolony. In children with lowrisk febrile neutropenia, consider. Reducing time to antibiotic administration for febrile neutropenia in the emergency department.
The national comprehensive cancer network nccn makes no representations or. Febrile neutropenia fn was defined as an oral temperature 38. Treatment of febrile neutropenia and prophylaxis in. The nccn guidelines and this illustration may not be reproduced in any form without the express written. The term neutropenic sepsis is also applied, although it tends to be reserved for patients who are less well. Fever may be the sole indicator of an underlying infection in patients with chemotherapyinduced neutropenia. Growth factors, nccn may add a febrile neutropenia risk level to the template if. Management of febrile neutropenia in adult cancer patients.
C over a onehour period in conjunction with an absolute neutrophil count. Predictors of severe and febrile neutropenia during primary. Predictors of severe and febrile neutropenia during. Antibacterial prophylaxis in patients with neutropenia. Febrile neutropenia is defined as a onetime oral temperature of greater than 38. Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer robin a. The febrile neutropenia risk level listed on the nccn templates is. Nccn clinical practice guidelines in oncology nccn guidelines. Febrile neutropenia remains a significant cause of morbidity, mortality, and cost burden in patients with cancer. Fever and neutropenia clinical practice guidelines in oncology. Prediction of neutropenia and of febrile neutropenia. If infection does occur in the setting of neutropenia, it can be severe and lifethreatening. Febrile neutropenia fn is a serious complication of cancer chemotherapy that can lead to delays in treatment and necessary dose reductions of chemotherapy, which compromise treatment efficacy.
Nccn guidelines prevention and treatment of cancerrelated. Guidelines in the management of febrile neutropenia for. It is associated with high rates of morbidity and mortality keng et al. Risk of febrile neutropenia associated with select. Fever may be the first or only sign that there is an underlying infection in neutropenic. Patients with neutropenia, or low neutrophil counts, are.
Patients suspected of having febrile neutropenia should undergo. America idsa,1 and is identical to the national comprehensive cancer network s nccn definition. In children with lowrisk febrile neutropenia, consider initial or stepdown outpatient management if infrastructure is in place to ensure careful monitoring and followup. A prospective study of chemotherapyinduced febrile neutropenia in the south west london cancer network. Prevention and treatment of cancerrelated infections. Febrile neutropenia mgfa patient risk factors for developing febrile neutropenia mgfb toxicity risks with growth factors mgfc patient risk factors for poor clinical outcomes or for developing infectionassociated complications mgfd myeloid growth factors for prophylaxis and treatment of febrile neutropenia. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. Febrile neutropenia fn is a serious complication of cancer. Mouthmucosal membrane, esophagus, and sinusnasal fev6. The clinical index of stable febrile neutropenia cisne is an emerging prognostic score for predicting serious complications in outpatients with solid tumors and stable fn episodes table 3. Fever during chemotherapyinduced neutropenia may be the only indication of a severe underlying infection, because signs and symptoms of in.
Febrile neutropenia fn is an oncological emergency and serious complication often resulting from chemotherapy. The nccn fever and neutropenia clinical practice guidelines in oncology have adopted a more permissive position regarding antibacterial prophylaxis. Guideline for the management of fever and neutropenia in. If the inline pdf is not rendering correctly, you can download the pdf file here.
Clinical practice guideline for the use of antimicrobial. The nccn guidelines state that for patients with a febrile neutropenia risk of 10% to 20%, prophylactic colonystimulating factor use should be considered based on the treatment intent and the importance of chemotherapy dose delivery on schedule. Fever and neutropenia clinical practice guidelines in oncology in. Febrile neutropenia is an oncologic emergency requiring immediate evaluation and treatment. Assessment of initial febrile neutropenia management in. The nccn and the asco guidelines for the use of growth factors recommend that all patients receiving highrisk chemotherapy should receive neutropenia prophylaxis with a granulocyte. Neutropenia may be accompanied by fever originating from an underlying infection. May 01, 2018 the panel continued to endorse consensus recommendations from the previous version of this guideline that patients with febrile neutropenia receive initial doses of empirical antibacterial therapy within 1 hour of triage and be monitored for. Febrile neutropenia is the most common lifethreatening complication of cancer therapy. Marrs, ms, aprnbc, aocnp neutropenia can be a signi.
Marrs, ms, aprnbc, aocnp, is a nurse practitioner at hematology and oncology associates of dayton in ohio. Myeloid growth factors for prophylaxis and treatment of febrile neutropenia and maintenance of scheduled dose. Nccn clinical practice guidelines in oncology nccn. Fever in neutropenic patients is classically defined as a single oral temperature of 38. The nccn compendium represents neither an allinclusive listing of every drug and biologic nor every appropriate use and indication for drugs and biologics. The risk of infection increases with the depth and duration of neutropenia. Society of america idsa, national comprehensive cancer network nccn. Nccn guidelines and nccn compendium nccn flash update sent march 3, 2014. Management and preventive measures for febrile neutropenia. These nccn clinical guidelines address many of the daytoday issues inherent in managing fever and neutropenia.
Physicians must be keenly aware of the infection risks, diagnostic methods, and antimicrobial therapies required for management of febrile patients through the. Patients with fn with high risk of complications should be initiated with empiric antibiotics administered intravenously in the hospital setting. Febrile neutropenia treatment algorithm bmj best practice. Define febrile neutropenia per infectious diseases society of america idsa and national comprehensive cancer network nccn guidelines outline an empiric antimicrobial regimen for a patient with febrile neutropenia recognize the differences between idsa and nccn febrile neutropenia guideline recommendations. Febrile neutropenia is defined as a single oral temperature measurement of 101f 38. Fever is defined as a single oral temperature measurement of 38. Febrile neutropenia fn is among the most serious clinical complications in patients with cancer who are undergoing chemotherapy. Carefully selected febrile adult neutropenic patients at low risk for complications during neutropenia may be treated initially with oral broadspectrum antibiotics 2, 2234, 4243, 45, 104. Nccn clinical practice guidelines in oncology recommend administration of primary prophylaxis with a myeloid growth factor in patients receiving regimens associated with a high risk for febrile neutropenia. If antibacterial prophylaxis generally with a quinolone is used, the nccn fever and neutropenia. Neutropenia, a decrease in the absolute neutrophil count anc, occurs frequently in recipients of chemotherapy. Define febrile neutropenia per infectious diseases society of america idsa and. Empiric antibiotic therapy upon presentation has dramatically improved outcomes and decreased mortality from febrile neutropenia. Febrile neutropenia, neutropenic fever, or fever and neutropenia.
At our institution, full compliance with the nccn febrile neutropenia. L or an absolute neutrophil count expected to decrease to less than 500 cells. If antibacterial prophylaxis generally with a quinolone is used, the nccn fever and neutropenia panel recommended that it be limited to patients expected to experience profound neu. About nccn flash updates nccn flash updates is a subscription service from nccn that provides timely notification of updated and new information appearing in the nccn guidelines, the nccn compendium, and other nccn content. The nccn guidelines and this illustration may not be reproduced in any form without the express written permission of nccn. C for 2 hours and an absolute neutrophil count febrile neutropenia fn is an oncological emergency and serious complication often resulting from chemotherapy.
Febrile neutropenia symptoms, diagnosis and treatment bmj. Therapeutic use of myeloid growth factors for febrile neutropenia mgf4 examples of disease settings and chemotherapy regimens with a high intermediate risk for febrile neutropenia mgfa gcsf for prophylaxis of febrile neutropenia. Initial risk assessment for febrile neutropenic patients fev2. The definition of febrile neutropenia fn is an unidentified source of single episode of fever 38. Evaluatio n of risk prediction criteria for episodes of febrile neutropenia in children with cancer. Accordingly, algorithmic approaches to fever and neutropenia, infection prophylaxis, diagnosis, and treatment. In general, the use of oral antibiotics may be considered only for patients who fulfill clear criteria for being at lowrisk for complications during. National comprehensive cancer network nccn guidelines outline an empiric antimicrobial regimen for a patient with febrile neutropenia recognize the differences between idsa and nccn febrile neutropenia guideline recommendations technicians. The nccn guidelines state that for patients with a febrile neutropenia risk of 10% to 20%, prophylactic colonystimulating factor use should be considered based on the treatment intent and the importance. Patients with a history of febrile neutropenia are at risk for subsequent episodes of febrile neutropenia, and many professional societies including the american society of clinical oncology asco, the national cancer center network nccn, and the european organisation for research and treatment of cancer eortc recommend the routine use of colonystimulating factors as secondary. Initial evaluation of fever and neutropenia fev1 initial risk assessment for febrile neutropenic patients fev2 outpatient therapy for lowrisk patients fev3 initial empiric therapy for fever and neutropenia. Pdf management of chemotherapy induced neutropenia an. Although, it is known that a neutropenic patient can be infected without fever or stay subfebrile, the definition of neutropenia is an absolute neutrophil count anc febrile neutropenia is the most common lifethreatening complication of cancer therapy.
March 11, 2019 nccn chemotherapy order templates nccn templates appendix c appendix c. Although, it is known that a neutropenic patient can be infected without fever or stay subfebrile, the definition of neutropenia is an absolute neutrophil count anc neutropenia. Clinical implications of febrile neutropenia guidelines in. Febrile neutropenia care guideline alexander sw, wade k, et al.
238 782 431 296 1231 979 515 1560 90 400 25 354 835 338 1523 874 1116 670 66 317 1167 751 718 483 207 310 54 218 917 97 325 610 1060 936 1240 862 925 152 1265 6